Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama.
Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
J Am Geriatr Soc. 2019 May;67(5):937-944. doi: 10.1111/jgs.15680. Epub 2018 Dec 3.
Little information is available on the long-term use of post-acute care among older patients with colorectal cancer (CRC), relative to individuals without cancer. This study examines the use of post-acute care among older cancer survivors (>65 y) with CRC and compares it with noncancer patients up to 5 years from surgery.
Retrospective cohort.
SEER-Medicare.
Patients treated for stage I to III CRC between January 1, 2000, and December 31, 2011 (n = 40 812) and noncancer Medicare beneficiaries hospitalized for noncancer treatment matching on age, sex, race, comorbidity, and Medicaid dual eligibility.
Incident post-acute care claims (skilled nursing, long-term care facility, and home health) from 0 to 100 days, 101 to 365 days, and 1 to 5 years from hospitalization.
The median age was 77 years. All patients had surgery, 34% received chemotherapy, and 27% received surgery and adjuvant therapy. The cumulative incidence of any post-acute care within 100 days of hospitalization was 45.7% for stage III, 37.9% for stage I/II, and 39% for controls (p < .001). Within the CRC cohort only, the cumulative incidence of post-acute care was 2.9% (stage I/II) and 4.2% (stage III, p < .001) from 101 to 365 days and 15.8% (stage I/II) and 16.9% (stage III, p < .001) from 1 to 5 years. Increasing age, ostomies, and neoadjuvant or adjuvant therapy were associated with increased hazard of all post-acute patients within 100 days from hospitalization. From 1 to 5 years from diagnosis, adjuvant therapy was associated with greater exclusive home health care use.
Survivorship planning among older CRC patients should include discussions of post-acute care following cancer therapy, even several years after treatment. J Am Geriatr Soc 67:937-944, 2019.
与非癌症患者相比,关于老年结直肠癌(CRC)患者在急性后期护理的长期使用情况的信息很少。本研究检查了年龄在 65 岁以上的癌症幸存者(CRC)在急性后期护理中的使用情况,并将其与手术 5 年内的非癌症患者进行了比较。
回顾性队列研究。
SEER-Medicare。
2000 年 1 月 1 日至 2011 年 12 月 31 日期间接受 I 期至 III 期 CRC 治疗的患者(n=40812)和因非癌症治疗住院的非癌症 Medicare 受益人,匹配年龄、性别、种族、合并症和 Medicaid 双重资格。
从住院后 0 至 100 天、101 至 365 天和 1 至 5 年的急性后期护理(熟练护理、长期护理机构和家庭健康)的发生率。
中位年龄为 77 岁。所有患者均接受了手术,34%接受了化疗,27%接受了手术和辅助治疗。在住院后 100 天内,任何急性后期护理的累积发生率为 III 期 45.7%、I/II 期 37.9%和对照组 39%(p<0.001)。仅在 CRC 队列中,101 至 365 天内急性后期护理的累积发生率为 2.9%(I/II 期)和 4.2%(III 期,p<0.001),1 至 5 年为 15.8%(I/II 期)和 16.9%(III 期,p<0.001)。年龄增长、造口术、新辅助或辅助治疗与住院后 100 天内所有急性后期患者的风险增加相关。从诊断后 1 至 5 年,辅助治疗与更多的家庭保健治疗有关。
对于老年 CRC 患者,生存规划应包括癌症治疗后急性后期护理的讨论,即使在治疗后几年也应进行讨论。J Am Geriatr Soc 67:937-944, 2019.